DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 88 filers reported holding DESIGN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,634,826 | -55.7% | 692,723 | +18.2% | 0.00% | – |
| Q2 2023 | $3,692,021 | -10.1% | 586,035 | -17.6% | 0.00% | – |
| Q1 2023 | $4,105,517 | -93.4% | 711,528 | -88.3% | 0.00% | -100.0% |
| Q4 2022 | $62,328,680 | +309.9% | 6,074,920 | +568.0% | 0.00% | +100.0% |
| Q3 2022 | $15,206,000 | +141.5% | 909,469 | +102.2% | 0.00% | – |
| Q2 2022 | $6,297,000 | -3.4% | 449,781 | +11.5% | 0.00% | – |
| Q1 2022 | $6,517,000 | -11.1% | 403,541 | +17.9% | 0.00% | – |
| Q4 2021 | $7,328,000 | +135.7% | 342,261 | +61.7% | 0.00% | – |
| Q3 2021 | $3,109,000 | -16.9% | 211,608 | +12.5% | 0.00% | – |
| Q2 2021 | $3,741,000 | – | 188,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 2,732,501 | $81,702,000 | 7.97% |
| Cormorant Asset Management, LP | 5,114,850 | $146,409,000 | 3.26% |
| Octagon Capital Advisors LP | 250,000 | $7,475,000 | 2.82% |
| EcoR1 Capital, LLC | 1,137,940 | $34,024,000 | 1.51% |
| RA Capital Management | 2,186,636 | $65,380,000 | 0.99% |
| Avoro Capital Advisors LLC | 1,468,318 | $39,702,000 | 0.69% |
| Vivo Capital, LLC | 530,991 | $15,877,000 | 0.56% |
| Rock Springs Capital Management LP | 327,250 | $9,785,000 | 0.21% |
| Artal Group S.A. | 400,000 | $11,960,000 | 0.21% |
| Baker Brothers Advisors | 1,436,636 | $42,955,000 | 0.19% |